BioCentury
ARTICLE | Company News

MorphoSys, Institute of Cancer Research deal

November 15, 2010 8:00 AM UTC

MorphoSys' research and diagnostic antibodies unit AbD Serotec received exclusive, worldwide rights to the institute's bromodeoxyuridine (BrdU) antibody clone, BU1/75, for research applications, inclu...